M K Proteins quarterly results and financials

M K Proteins (MKPL)₹3.95−0.25%(9 Nov 2026 close)Edible Oil

Key facts

In the Mar 2026 quarter (standalone), M K Proteins reported sales of ₹147 Cr, up 6.3% from Mar 2025, and net profit of ₹1.13 Cr, down 59.5% year on year. For the year to Mar 2026, sales were ₹385 Cr and net profit ₹6.99 Cr.

Sales (Mar 2026): ₹147 Cr
Net profit (Mar 2026): ₹1.13 Cr
Sales (FY Mar 2026): ₹385 Cr
Net profit (FY Mar 2026): ₹6.99 Cr
EPS (Mar 2026): ₹0.04
Borrowings (Mar 2026): ₹36.89 Cr

Company filings, standalone accounts; latest reported quarter Mar 2026

M K Proteins quarterly results

₹ crore unless stated; each column is a quarter.

M K Proteins Quarterly results
	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	76.45	13.68	69.12	87.20	57.54	33.84	39.63	138	115	32.58	89.92	147
Expenses	72.43	13.05	65.51	78.76	53.76	31.58	37.83	133	110	31.49	87.46	144
Operating Profit	3.98	0.63	3.55	8.40	3.73	2.22	1.78	4.63	5.49	1.03	2.36	2.49
OPM %	5.2%	4.7%	5.1%	9.7%	6.5%	6.6%	4.5%	3.4%	4.8%	3.2%	2.6%	1.7%
Other Income	0.00	0.02	0.00	0.40	0.00	0.20	0.24	0.01	0.00	0.11	0.01	0.11
Interest	0.51	0.03	0.10	0.39	0.32	0.02	0.06	0.66	0.69	0.05	0.29	0.78
Depreciation	0.13	0.13	0.13	0.19	0.08	0.08	0.12	0.10	0.11	0.12	0.13	0.12
Profit before tax	3.34	0.50	3.33	8.24	3.33	2.33	1.85	3.90	4.70	0.98	1.96	1.71
Tax %	25.7%	21.6%	25.7%	29.4%	25.4%	25.2%	25.8%	28.7%	25.3%	25.2%	26.9%	33.7%
Net Profit	2.48	0.40	2.47	5.82	2.47	1.73	1.37	2.79	3.50	0.74	1.42	1.13
EPS (Rs)	0.08	0.02	0.08	0.17	0.08	0.06	0.05	0.08	0.10	0.03	0.05	0.04

M K Proteins profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

M K Proteins Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	146	166	173	158	195	312	257	316	246	269	385	385
Expenses	142	160	167	153	190	296	241	299	230	256	373	373
Operating Profit	3.99	4.98	5.98	4.98	4.98	15.95	15.94	16.94	16.94	12.95	10.97	11.37
OPM %	2.9%	3.0%	3.2%	3.2%	2.5%	5.0%	6.0%	5.0%	7.0%	4.7%	3.0%	3.0%
Other Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.99	0.00	0.00	0.00	0.23
Interest	1.99	1.99	1.99	1.99	1.99	0.99	1.01	1.99	0.99	0.99	1.99	1.81
Depreciation	1.01	1.01	1.01	1.01	1.01	1.01	1.01	1.01	1.01	0.00	0.00	0.48
Profit before tax	0.99	1.99	1.99	1.99	1.99	13.96	13.97	14.96	14.96	10.98	8.98	9.35
Tax %	31.0%	35.0%	35.0%	28.0%	26.0%	27.0%	27.0%	27.0%	28.0%	27.0%	27.0%	—
Exceptional items	0.00	0.00	0.00	0.03	0.04	0.04	0.05	0.02	0.04	0.33	0.00	—
Net Profit	0.99	0.99	0.99	1.99	1.99	9.98	9.99	10.99	10.98	7.99	6.99	6.79
EPS (Rs)	1.21	0.05	0.05	0.05	0.06	0.29	0.28	0.30	0.31	0.23	0.19	0.22
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

M K Proteins balance sheet

₹ crore, at each year end.

M K Proteins Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	0.67	0.67	2.99	3.99	3.99	3.99	3.99	3.99	12.97	37.92	37.90	37.92
Reserves	1.99	2.99	1.99	10.96	12.95	14.95	24.90	34.89	36.85	23.89	31.91	38.87
Borrowings	19.96	25.95	30.97	32.91	25.94	30.93	24.94	36.93	45.89	19.95	38.91	36.89
Other Liabilities	12.98	9.95	11.94	7.96	4.00	6.96	13.01	9.98	7.97	14.94	22.02	17.91
Total Liabilities	34.92	38.88	46.89	55.82	46.88	56.83	66.84	85.79	103	95.70	131	131
Fixed Assets	5.98	6.97	6.97	5.98	3.99	2.99	1.99	2.99	2.99	2.99	3.99	4.98
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	6.01	7.01	7.01
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	28.94	31.91	39.92	49.84	42.89	52.84	64.85	82.80	99.69	87.70	120	119
Inventories	21.99	19.99	33.03	30.04	29.01	39.04	38.03	50.01	71.07	79.02	111	110
Trade receivables	4.99	10.99	5.01	19.01	11.01	10.01	20.99	28.98	16.01	4.01	0.99	2.01
Cash & equivalents	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	34.92	38.88	46.89	55.82	46.88	56.83	66.84	85.79	103	95.70	131	131

M K Proteins cash flow

₹ crore, for each year.

M K Proteins Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	10.96	−3.99	−3.98	−11.96	5.98	−3.98	5.98	−9.97	−5.98	31.87	−15.93	4.98
Cash from investing activity	0.00	−2.01	−1.01	0.00	0.00	0.00	0.00	−2.01	0.00	−6.01	−1.01	−1.99
Cash from financing activity	−9.99	5.99	4.99	11.99	−6.99	3.99	−4.99	11.99	5.99	−26.97	17.97	−2.99
Net cash flow	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Capex	0.49	1.77	1.01	0.04	0.00	0.00	0.25	1.59	0.00	5.88	2.21	0.00
Free cash flow	9.99	−5.99	−4.99	−11.99	5.99	−3.99	4.99	−11.98	−5.99	26.98	−17.98	3.99
CFO / OP %	267.0%	−92.0%	−65.0%	−201.9%	150.1%	−76.9%	44.1%	−39.0%	−6.0%	216.1%	−95.0%	70.0%

M K Proteins ratios

Working-capital days and returns, by year.

M K Proteins Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	15	26	9	38	24	17	23	41	18	4	1	1
Inventory days	70	57	83	69	75	79	48	80	91	134	170	114
Days payable	40	23	24	13	7	9	11	9	7	20	30	6
Cash conversion cycle	48	63	71	98	95	90	63	115	105	121	143	111
Working capital days	11	9	20	44	32	36	36	55	57	77	81	62
ROCE %	14.0%	13.0%	12.0%	11.0%	8.0%	8.0%	29.0%	23.0%	20.0%	19.0%	13.0%	10.0%

M K Proteins: frequently asked questions

What are the latest quarterly results of M K Proteins?

For the Mar 2026 quarter, M K Proteins reported sales of ₹147 Cr, up 6.3% year on year and net profit of ₹1.13 Cr, down 59.5% year on year. The operating margin was 1.7%.

What is the annual revenue of M K Proteins?

M K Proteins' sales for the year to Mar 2026 were ₹385 Cr; over the last twelve months they were ₹385 Cr.

What is the net profit of M K Proteins?

Net profit for the year to Mar 2026 was ₹6.99 Cr, and ₹6.79 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.22.

How much debt does M K Proteins have?

M K Proteins reported borrowings of ₹36.89 Cr at Mar 2026, against cash and equivalents of ₹0 Cr.

What is the free cash flow of M K Proteins?

Cash from operations was ₹4.98 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹3.99 Cr.

Loading…